Is a complete XBIT research report available?

No complete published report is available for XBiotech Inc. (XBIT) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

XBiotech Inc. (XBIT)

NASDAQ: XBIT · USD

$2.26

-0.01 (-0.4%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-28 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first XBIT analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	68.9M
Net income (ttm)	-40.2M
EPS (ttm)	-$1.32
Shares out	30.5M
Volume	30,061
Beta	0.84

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -40.2M
EPS (ttm): -$1.32
Market cap: 68.9M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All XBIT indicators

Market & fundamental data

Available fields

174

Groups with data

Currency

USD

Showing 174 of 174 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001626878
Company name	XBiotech Inc.
Country	United States
Country code	US
Cusip	98400H102
Employees	87
Employees Change	-3%
Employees Change Percent	-3.33
Enterprise value	$-46.6M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2015-04-15
Isin	CA98400H1029
Last refreshed	2026-07-28
Market cap	$68.9M
Market cap category	Micro-Cap
Price	$2.26
Price currency	USD
Sector	Healthcare
Sector PE	44.88
Sector PE Fwd	23.87
Sic	2834
Symbol	XBIT
Website	https://www.xbiotech.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-58.29%
FCF yield	-61.48%
P/B ratio	0.51x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-40.2M
Net Income Growth Quarters	1%
Net Income Growth Years	0%
Profit Per Employee	$-461,621
ROA	-18.81
Roa5y	-11.12
ROCE	-35.38
ROE	-25.93
Roe5y	-15.34
ROIC	-281.8
Roic5y	-176.1

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-15.34%
Cagr1y	-21.27%
Cagr3y	-25.29%
Cagr5y	-32.44%
EPS Growth Quarters	1
EPS Growth Years	0
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$139.8M
Cash	$115.5M
Current Assets	$117M
Current Liabilities	$3M
Debt	$0
Equity	$135M
Liabilities	$4.8M
Long Term Assets	$22.8M
Long Term Liabilities	$1.8M
Net Cash	$115.5M
Net Cash By Market Cap	$168
Net Cash Growth	-25.94%
Net Debt Equity	$-0.86
Tangible Book Value	$135M
Tangible Book Value Per Share	$4.43
WACC	8.89

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	39.03
Net Working Capital	$-1.4M
Quick ratio	38.6
Working Capital	$114.1M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.05%
Dividend per share	$0
Dividend Yield	0%
Last Dividend	$2.47

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-81.07%
1Y total return	-21.25%
200-day SMA	2.42
3Y total return	-58.3%
50-day SMA	2.35
50-day SMA vs 200-day SMA	50under200
5Y total return	-85.92%
All Time High	32.5
All Time High Change	-93.05%
All Time High Date	2015-04-21
All Time Low	2.09
All Time Low Change	8.13%
All Time Low Date	2025-11-05
ATR	0.05
Beta	0.84
Beta1y	0.48
Beta2y	1.02
Ch YTD	-5.44
High	2.27
High52	3.61
High52 Date	2025-08-26
High52ch	-37.4%
Low	2.25
Low52	2.09
Low52 Date	2025-11-05
Low52ch	8.13%
Ma50ch	-3.79%
Price vs 200-day SMA	-6.5%
RSI	40.7
RSI Monthly	38.28
RSI Weekly	39.97
Sharpe ratio	-0.34x
Sortino ratio	-0.42
Total Return	-0.05%
Tr YTD	-5.44
Tr1m	-3%
Tr1w	0.44%
Tr3m	-9.96%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$-48.4M

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	22,837,624%
Float Percent	74.91%
Shares Insiders	25.09%
Shares Institutions	6.78%
Shares Out	30,487,731
Shares Qo Q	0%
Shares Yo Y	0.05%
Short Float	1.23%
Short Ratio	7.8
Short Shares	0.92

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-42.8M
Adjusted OCF	-42,634,000
Average Volume	42,667.55x
Bv Per Share	4.43
CAPEX	$-195,000
Ch10y	-83.66
Ch1m	-3
Ch1w	0.44
Ch1y	-21.25
Ch3m	-9.96
Ch3y	-58.3
Ch5y	-85.92
Ch6m	-15.99
Change	-0.44%
Change From Open	0
Close	2.27
Days Gap	-0.44
Depreciation Amortization	1,576,000
Dollar Volume	67,937.9
Earnings Date	2026-08-12
EBIT	$-48.4M
EBITDA	$-46.8M
EPS	$-1.32
F Score	1
FCF	$-42.4M
FCF EV Yield	90.99x
FCF Per Share	$-1.39
Fiscal Year End	December
Founded	2,005
Income Tax	$255,000
Investing CF	-186,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-14
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-03-13
Ma150	2.41
Ma150ch	-6.07%
Ma20	2.3
Ma20ch	-1.74%
Net CF	-40,438,000
Next Earnings Date	2026-08-12
Open	2.26
Optionable	Yes
Position In Range	50
Ppne	22,787,000
Price Date	2026-07-27
Ptbv Ratio	0.51
Relative Volume	0.7x
Share Based Comp	465,000
Tr6m	-15.99%
Us State	Texas
Volume	30,061

XBiotech Inc. (XBIT)

Coverage state: Market snapshot only — no published research

Generate the first XBIT analysis

Price

Financial snapshot

Fair-value bridge

Latest news · XBIT

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All XBIT indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on XBIT

Frequently asked questions